Aberrant p53 expression and the development of gallbladder carcinoma and adenoma

Kaohsiung Journal of Medical Sciences

Volumn 22, Issue 2, 2006, Pages 53-59

  Wang, Shen Nien ^a   Chung, Shin Chang ^a   Tsai, Kun Bow ^a   Chai, Chee Yin ^a   Chang, Wen Tsun ^a   Kuo, Kung Kai ^a   Chen, Jong Shyone ^a   Lee, King Teh ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Gallbladder adenoma; Gallbladder carcinoma; Immunohistochemistry; p53

Indexed keywords

PROTEIN P53;

ADENOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTADENOMA; DISEASE COURSE; FEMALE; GALLBLADDER CARCINOMA; GENE EXPRESSION REGULATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; RARE DISEASE; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE;

EID: 33644961034     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1607-551x(09)70221-9     Document Type: Article

References (24)

1. Cubertafond P, Mathonnet M, Gainant A, et al. Radical surgery for gallbladder cancer. Results of the French Surgical Association Survey. Hepatogastroenterology 1999;46:1567-71.
2. Donohue JH, Stewart AK, Menck HR. The National Cancer Data Base report on carcinoma of the gallbladder, 1989-1995. Cancer 1998;83:2618-28.
3. Lazcano-Ponce EC, Miquel JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001;51:349-64.
4. Misra S, Chaturvedi A, Misra NC, et al. Carcinoma of the gallbladder. Lancet Oncol 2003;4:167-76.
5. Chao TC, Wang CS, Jeng LB, et al. Primary carcinoma of the gallbladder in Taiwan. J Surg Oncol 1996;61:49-55.
6. Yang TL, Liu CL, Liu TP, et al. Primary carcinoma of the gallbladder: results of surgery-a retrospective study. Zhonghua Yi Xue Za Zhi (Taipei) 1999;62:68-75.
7. Yokoyama N, Watanabe H, Ajioka Y, et al. [Genetic alterations in gallbladder carcinoma: a review]. Nippon Geka Gakkai Zasshi 1998;99:687-95.
8. Itoi T, Watanabe H, Ajioka Y, et al. APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gallbladder carcinogenesis. Pathol Int 1996;46:333-40.
9. Kozuka S, Tsubone N, Yasui A, et al. Relation of adenoma to carcinoma in the gallbladder. Cancer 1982;50:2226-34.
10. Yokoyama N, Hitomi J, Watanabe H, et al. Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile. Cancer Epidemiol Biomarkers Prev 1998;7:297-301.
11. Sessa F, Furlan D, Genasetti A, et al. Microsatellite instability and p53 expression in gallbladder carcinomas. Diagn Mol Pathol 2003;12:96-102.
12. Koda M, Yashima K, Kawaguchi K, et al. Expression of Fhit, Mlh1, and p53 protein in human gallbladder carcinoma. Cancer Lett 2003;199:131-8.
13. Misra S, Chaturvedi A, Goel MM, et al. Over-expression of p53 protein in gallbladder carcinoma in North India. Eur J Surg Oncol 2000;26:164-7.
14. Albores-Saavedra J, Henson DE, Sobin LH. The WHO Histological Classification of Tumors of the Gallbladder and Extrahepatic Bile Ducts. A commentary on the second edition. Cancer 1992;70:410-4.
15. Chung SC, Lee KT, Tsai KB, et al. Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers. World J Surg 2004;28:995-1000.
16. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-10.
17. Misra S, Chaturvedi A, Misra NC. Carcinoma gallbladder presenting with skeletal metastases. Indian J Gastroenterol 1997:69-87.
18. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates. Cancer 1992;70:1498-501.
19. Itoi T, Watanabe H, Yoshida M, et al. Correlation of p53 protein expression with gene mutation in gall-bladder carcinomas. Pathol Int 1997;47:525-30.
20. Sasatomi E, Tokunaga O, Miyazaki K. Precancerous conditions of gallbladder carcinoma: overview of histopathologic characteristics and molecular genetic findings. J Hepatobiliary Pancreat Surg 2000;7:556-67.
21. Takei K, Watanabe H, Itoi T, et al. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder. Pathol Int 1996;46:908-17.
22. Yim H, Jin YM, Shim C. Tubular adenoma of the gallbladder with spindle cell metaplasia. J Korean Med Sci 1998;13:295-8.
23. Wistuba II, Albores-Saavedra J. Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma. J Hepatobiliary Pancreat Surg 1999;6:237-44.
24. Watanabe H, Date K, Itoi T, et al. Histological and genetic changes in malignant transformation of gallbladder adenoma. Ann Oncol 1999;10:136-9.